Is the Exclusive Sale Rights a system only for top listed pharmaceutical companies?
The industry has paid attention on the pharmaceuticalamendment followed afteradoption the Patent Linkage System Sales Restriction Rights, which is pending in the National Assembly.
An argument has been raised that the ‘Exclusive Sale Rights System’ in the amendment will be a countermeasure again...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
